While IL-15 alone has a short half-life, administration of IL-15 linked to soluble IL-15Rα significantly increases its half-life [17], leading to improved in vivo tumor response through increased survival of memory T and NK cells [17, 18]. Here, IL15 is linked to neoplasm.